Imbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological target (2012)
- Authors:
- Autor USP: SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidade: FMRP
- Subjects: ARTERIOSCLEROSE; DOENÇAS CARDIOVASCULARES; INSUFICIÊNCIA RENAL CRÔNICA; METALOPROTEINASES; UREMIA
- Language: Inglês
- Imprenta:
- Publisher place: West Sussex
- Date published: 2012
- Source:
- Título do periódico: Basic and Clinical Pharmacology and toxicology
- ISSN: 1742-7851
- Volume/Número/Paginação/Ano: v. 110, n. 5, p. 409-415, 2012
-
ABNT
MARSON, Bernardo P.; FIGUEIREDO, Carlos E. Poli de; SANTOS, José Eduardo Tanus dos. Imbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological target. Basic and Clinical Pharmacology and toxicology, West Sussex, v. 110, n. 5, p. 409-415, 2012. Disponível em: < http://dx.doi.org/10.1111/j.1742-7843.2012.00863.x >. -
APA
Marson, B. P., Figueiredo, C. E. P. de, & Santos, J. E. T. dos. (2012). Imbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological target. Basic and Clinical Pharmacology and toxicology, 110( 5), 409-415. Recuperado de http://dx.doi.org/10.1111/j.1742-7843.2012.00863.x -
NLM
Marson BP, Figueiredo CEP de, Santos JET dos. Imbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological target [Internet]. Basic and Clinical Pharmacology and toxicology. 2012 ; 110( 5): 409-415.Available from: http://dx.doi.org/10.1111/j.1742-7843.2012.00863.x -
Vancouver
Marson BP, Figueiredo CEP de, Santos JET dos. Imbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological target [Internet]. Basic and Clinical Pharmacology and toxicology. 2012 ; 110( 5): 409-415.Available from: http://dx.doi.org/10.1111/j.1742-7843.2012.00863.x - Sequence diversity and functional charactterization of the 5´-regulatory region of human cyp2c19
- Uncontrolled hypertension, uncompensated type II diabetes, and smoking have different patterns of vascular dysfunction
- Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6
- Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes
- Estudo de associação de haplótipos da Enos e insuficiência renal crônica
- Estudo de associação entre polimorfismo no sistema da aldesterona e hipertensão refratária
- eNOS gene polymorphirms may modify the effects produced by cardiovascular drugs on myocardial eNOS expression and activity [Carta]
- Xanthine oxidoreductase contributes to vasodillation and antihypertensive effects of sodium nitrite in renovascular hypertension
- Nitrate decreases xanthine oxidoreductase-mediated nitrite reductase activity and attenuates vascular and blood pressure responses to nitrite
- Functional polymorphism located in MMP-9 gene promoter is strongly associated with obesity
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
